Stock Blog Hub » CFN

(OMCL) Omnicell Analyst Reaffirms Shares at Neutral

vitalstocks — Wed, 14 Dec 2011 20:11:18 +0000

We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $17.00. Omnicell reported adjusted EPS of 9 cents in the third quarter of fiscal 2011, beating the Zacks Consensus Estimate by a penny and the year-ago quarter EPS of 4 cents. Revenues in the reported quarter increased 5.6% year over year [...]

(OMCL) Omnicell Analyst Reaffirms Shares at Neutral

(CAH) Cardinal Health Analyst Maintains Outperform on Shares

vitalstocks — Wed, 07 Dec 2011 17:53:10 +0000

We reiterate our Outperform rating on Cardinal Health (CAH). Its first-quarter fiscal 2012 (ended September 30) adjusted earnings per share of 73 cents beat the Zacks Consensus Estimate of 72 cents. Earnings from continuing operations (as reported) dropped about 19% year over year reflecting a previous-year gain from the sale of CareFusion (CFN) shares. Sales [...]

(CAH) Cardinal Health Analyst Maintains Outperform on Shares

(OMCL) Omnicell’s G4 Platform Reaches China

vitalstocks — Wed, 30 Nov 2011 19:57:39 +0000

Recently, Omnicell (OMCL) announced the launch of Mandarin-language versions of its G4 platform for clinical use in China. Following the launch of G4 medication automation platform in English-speaking markets earlier this year, the language conversion of medication cabinets will enable Chinese hospitals to utilize all the advanced operational improvements of G4. The latest move on [...]

(OMCL) Omnicell’s G4 Platform Reaches China

(OMCL) Omnicell Beats Estimates

vitalstocks — Fri, 04 Nov 2011 18:57:59 +0000

Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot up 125% on a year-over-year basis primarily due to the reduction in effective tax rate from 60% in the year-ago [...]

(OMCL) Omnicell Beats Estimates

(OMCL) Omnicell Analyst Maintains Neutral on Shares

vitalstocks — Tue, 20 Sep 2011 20:17:32 +0000

We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00. Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate and the year-ago quarter’s EPS of 6 cents. Total revenue for the second quarter was $61.0 million, up 6.6% [...]

(OMCL) Omnicell Analyst Maintains Neutral on Shares

(AOL) Company News for August 10, 2011 – Corporate Summary

vitalstocks — Wed, 10 Aug 2011 20:40:24 +0000

• AOL (NYSE:AOL) reported a loss Q2 EPS of $0.11, against the Zacks Consensus Estimate of a profit of $0.02 per share. Revenues for the quarter declined by 8% to $542.2 million• Snyder’s-Lance (NASDAQ:LNCE) posted Q2 EPS of $0.16, ex-items, missing the Zacks Consensus Estimate of $0.18 per share. Revenues for the quarter increased by [...]

(AOL) Company News for August 10, 2011 – Corporate Summary

(CFN) CareFusion Buying Rowa for $150 Million

vitalstocks — Tue, 12 Jul 2011 16:57:24 +0000

Medical technology company CareFusion Corporation (CFN) recently made a deal to buy German medication storage systems maker Rowa GmbH for roughly $150 million. Rowa, which has customers in 30 countries, specializes in high-speed robotic medication storage and retrieval systems for retail and hospital pharmacies. The company has deployed more than 3,500 automation systems in retail [...]

(CFN) CareFusion Buying Rowa for $150 Million

(OMCL) Omnicell’s Electronic Health Record Wins Certification

vitalstocks — Wed, 22 Jun 2011 17:01:42 +0000

Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification as a Modular Electronic Health Record (“EHR”). Omnicell became the first hospital pharmacy automation company to achieve this certification and the company intends to support its clients [...]

(OMCL) Omnicell’s Electronic Health Record Wins Certification

(OMCL) Omnicell Earns Second Consecutive Best in Klas Award

vitalstocks — Sun, 19 Jun 2011 17:33:41 +0000

Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year. Along with the 2011 “Best in KLAS” award for Automated Medication Dispensing Units for large hospitals with more than 200 beds category, Omnicell was also recognized as the Category Leader [...]

(OMCL) Omnicell Earns Second Consecutive Best in Klas Award

(CAH) Cardinal Health Third Quarter 2011 Earnings Preview

vitalstocks — Wed, 27 Apr 2011 17:28:55 +0000

Cardinal Health (CAH) is slated to report its third-quarter fiscal 2011 (ending March) results on Thursday, April 28. The company expects earnings per share in the range of $2.54 to $2.60 for fiscal 2011. The current Zacks Consensus Estimate for revenues and earnings for the third quarter are $25.6 billion and 69 cents per share, [...]

(CAH) Cardinal Health Third Quarter 2011 Earnings Preview

(CAH) Cardinal Health Gets Antitrust Clearance

vitalstocks — Mon, 20 Dec 2010 20:27:38 +0000

Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination of waiting period, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, for the planned [...]

(CAH) Cardinal Health Gets Antitrust Clearance

(CAH) Cardinal Health Announces Buy of Kinray

vitalstocks — Sun, 19 Dec 2010 23:25:20 +0000

Cardinal Health (CAH) recently announced plans to purchase Kinray Inc., a leading pharma distributor with a presence in the New York metropolitan area. The cash deal will enhance Cardinal’s capability to cater to retail independent pharmacies in the northeastern U.S. markets. Cardinal expects to close the deal by the end of the current calendar year, [...]

(CAH) Cardinal Health Announces Buy of Kinray

(CAH) Cardinal Health Prepares for Coming Flu Season

vitalstocks — Mon, 04 Oct 2010 05:13:42 +0000

Cardinal Health (CAH) is taking necessary steps to maintain the supply of influenza vaccines during the forthcoming 2010-2011 flu season. For the first time, the Advisory Committee on Immunization Practices (ACIP) has been asking everyone over 6 months of age to get a flu vaccine. The company is of the opinion that the supplies are [...]

(CAH) Cardinal Health Prepares for Coming Flu Season

(CAH) Cardinal Health Sells Remaining CareFusion Shares

vitalstocks — Sun, 19 Sep 2010 17:57:49 +0000

Cardinal Health (CAH), a leading distributor of pharmaceuticals and medical supplies, recently sold off the remaining 30.5 million shares of CareFusion Corporation (CFN) for $705.9 million. CareFusion, a San Diego-based vendor for medical equipment and infection control supplies, was spun off from Cardinal Health in 2009. As per the spin-off arrangement, Cardinal Health distributed 0.5 [...]

(CAH) Cardinal Health Sells Remaining CareFusion Shares

(CAH) Cardinal Health Earnings Scorecard

vitalstocks — Thu, 12 Aug 2010 05:16:19 +0000

Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, recently reported earnings for fourth-quarter of fiscal year 2010, which beat the Zacks Consensus Estimate by a penny. Revenues grew by a mere 0.5% year over year to $22.3 billion. Pharmaceutical revenues were essentially flat year over year as higher sales to [...]

(CAH) Cardinal Health Earnings Scorecard

(CAH) Cardinal Health’s Report Beats Expectations by a Penny

vitalstocks — Fri, 06 Aug 2010 16:56:23 +0000

Cardinal Health (CAH) reported fourth-quarter and fiscal 2010 adjusted (excluding one-time expenses) earnings per share of 50 cents and $2.22 respectively, exceeding the Zacks Consensus Estimates of 49 cents and $2.21, respectively, but below the year-ago results of 63 cents and $2.26, respectively. Revenues Total revenue was $24.5 billion in the fourth quarter, up by [...]

(CAH) Cardinal Health’s Report Beats Expectations by a Penny

(CAH) Cardinal Health Earnings Preview

vitalstocks — Tue, 03 Aug 2010 04:23:56 +0000

Cardinal Health (CAH) is slated to report fourth-quarter and fiscal 2010 (ending June 30, 2010) results on Thursday, August 5, 2010. The company earlier issued earnings per share guidance in the range of $2.15 to $2.20 for fiscal 2010. The current Zacks Consensus Estimate for the fourth quarter is 49 cents, representing an estimated 43.2% [...]

(CAH) Cardinal Health Earnings Preview

(HSP) Hospira Second Quarter 2010 Earnings Preview

vitalstocks — Mon, 02 Aug 2010 21:52:31 +0000

Hospira Inc. (HSP) is scheduled to report its second quarter 2010 results on Wednesday, July 28, before the opening bell. The Zacks Consensus Estimate for the quarter is earnings of 79 cents per share (with an upside of 2.53%), compared with earnings of 73 cents per share in the year-earlier period. The Zacks Consensus Estimate [...]

(HSP) Hospira Second Quarter 2010 Earnings Preview

(CFN) CareFusion Decides to Acquire Medegen for $225 Million

vitalstocks — Thu, 08 Apr 2010 00:24:51 +0000

CareFusion Corporation (CFN) has decided to acquire Medegen for $225 million in cash. CareFusion expects the acquisition to be neutral to the adjusted earnings per share in the first year of operations and increasingly accretive thereafter. The acquisition is expected to be completed by June 30, 2010. Medegen is a leading innovator in infusion therapy [...]

(CFN) CareFusion Decides to Acquire Medegen for $225 Million

(CFN) CareFusion Corporation Beats Consensus Estimates

vitalstocks — Thu, 11 Feb 2010 00:21:08 +0000

CareFusion Corporation (CFN) recently reported second quarter fiscal 2010 earnings per share of 39 cents, marginally beating the Zacks Consensus Estimate of 38 cents, but lower than the year-ago earnings of 50 cents. Total revenues in the second quarter increased 5% year over year to $1.0 billion. Growth was witnessed across all business segments. Critical [...]

(CFN) CareFusion Corporation Beats Consensus Estimates

(CAH) Cardinal Health Upgraded to Outperform

vitalstocks — Wed, 10 Feb 2010 21:17:07 +0000

We have recently upgraded Cardinal Health Inc. (CAH) to “Outperform” with a target price of $37 based on approximately 15.7x our fiscal 2011 EPS estimate of $2.36. Cardinal Health reported second quarter fiscal 2010 earnings per share of 57 cents, beating the Zacks Consensus Estimate of 46 cents and the year-ago earnings of 51 cents. [...]

(CAH) Cardinal Health Upgraded to Outperform

(FOSL) Flies in the Ointment

Wax — Tue, 02 Feb 2010 18:18:32 +0000

We had several e-mails over the recent holidays asking what we did with research for companies we had decided not to pursue and would we consider sharing that research with others. Unlike most folks, we do not use stock screens. We see something on the web, or read something in a periodical, or are asked [...]

(FOSL) Flies in the Ointment

(CFN) CareFusion Corporation Enters Agreement with Masimo

vitalstocks — Sat, 14 Nov 2009 22:12:01 +0000

CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow SET Pulse CO-Oximetry technology in CareFusion infusion and respiratory products, which are presently under development. The agreement enables CareFusion’s future infusion and respiratory products to non-invasively and continuously measure multiple blood constituents to more accurately [...]

(CFN) CareFusion Corporation Enters Agreement with Masimo